| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Agenus Inc (AGEN) has 9 insiders with recent SEC Form 4 filings, including 4 buys and 7 sells. AGEN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 346.8K | $1.32M | - | |
| Dir | 210.0K | $802.2K | - | |
| Dir | 122.5K | $467.9K | - | |
| Dir | 105.0K | $401.1K | - | |
| Dir | 105.0K | $401.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 13, 2021 | Armen Garo H49 | Chairman And CEO | Sale+OE | 82,107 | $6.50 | $533,695.50 | -9.6% | -49.4% | -60.8% | |
| Sep 10, 2021 | Klaskin Christine M | Pfo &Pao | Sale+OE | 11,120 | $6.50 | $72,280.00 | -10.7% | -50.6% | -58.6% | |
| Dec 12, 2017 | Baysal Ozer | Chief Commercial Officer | Sell | 3,712 | $3.46 | $12,845.75 | -5.9% | - | - | |
| Dec 12, 2017 | Buell Jennifer | Chief Communications Officer | Sell | 3,511 | $3.46 | $12,151.92 | -9.0% | - | - | |
| Dec 12, 2017 | Duncan Alex | Chief Technology Officer | Sell | 6,546 | $3.46 | $22,651.12 | -23.7% | - | - | |
| Dec 12, 2017 | Klaskin Christine M | VP, Finance | Sell | 5,610 | $3.46 | $19,417.89 | -8.0% | - | - | |
| Dec 12, 2017 | Valentine Karen | Chief Legal Officer | Sell | 8,358 | $3.46 | $28,921.19 | -7.6% | - | - | |
| Apr 12, 2017 | Armen Garo H49 | Chairman &CEO | Buy | 100,000 | $3.35 | $334,519.79 | +3.7% | - | - | |
| Feb 14, 2017 | Incyte Corp | 10% Owner | Buy | 10,000,000 | $6.00 | $60,000,000.00 | +128.8% | - | - | |
| Sep 6, 2016 | Wiinberg Ulf52 | Director | Buy | 30,000 | $6.29 | $188,700.00 | New | - | - |